Back to Home

Healthcare Affordability

Expert articles and analysis related to healthcare affordability.

136 articles‱Last 24 Hours

AI Summary — Last 24 Hours

Federal affordability policy is tightening around Medicaid and Medicare: a Senate Budget Committee hearing kept pressure on One Big Beautiful Bill Act Medicaid provisions, with conservative lawmakers arguing federal cuts and work requirements can streamline spending while providers and states face coverage-loss and uncompensated-care risk—especially for rural and homeless populations (HFMA). For VBC organizations, the immediate concern is attribution and risk-pool disruption as Medicaid eligibility churn, ACA marketplace morbidity reportedly worsens, and Medicare Advantage plans like Clover Health lean on membership growth and Star Ratings to improve outlooks—raising the stakes for population health infrastructure, risk adjustment, and retention. CMS also released the FY 2026 IPPS final rule, while scrutiny of Medicare drug price-negotiation timing signals continued affordability pressure across hospital payment, Part D economics, and total-cost-of-care models.

Related Articles

95ALN

STAT+: Medicare quietly gave blockbuster AbbVie drug seven extra years before price negotiations, advocacy group asserts

A little-noticed government policy shift caused a seven-year delay in choosing a costly medicine for Medicare price negotiations, an advocacy group says.

STAT NewsAug 6, 2026
95ALN

How Much and Why Premiums Are Going Up for Small Businesses in 2027

Small businesses that offer health insurance to their employees could see health costs rise in 2027, according to an analysis of preliminary rate filings from all 50 states and DC. Nearly 300 insurers...

KFFAug 6, 2026
95ALN

Myths Of Mandatory International Reference Pricing For Prescription Drugs

Myths Of Mandatory International Reference Pricing For Prescription Drugs  Health Affairs

Health AffairsAug 6, 2026
90ALN

Judge signs off on Teva's $35M settlement over delayed inhaler generics

A Massachusetts federal judge on Wednesday approved a $35 million settlement between Teva Pharmaceuticals and a handful of healthcare funds over allegations the company delayed generic versions of its...

Endpoints NewsAug 6, 2026
90ALN

Arizona erases $1B in medical debt

Arizona erases $1B in medical debt  Becker's Hospital Review

Becker's Hospital ReviewAug 6, 2026
90ALN

HRSA to Launch Revised 340B Rebate Model Next Year

HRSA to Launch Revised 340B Rebate Model Next Year  American Health Law Association

AHLAAug 6, 2026
90ALN

On Cell And Gene Therapies, Payers And Providers Should Collaborate To Enhance Access And Affordability

On Cell And Gene Therapies, Payers And Providers Should Collaborate To Enhance Access And Affordability  Health Affairs

Health AffairsAug 6, 2026
90ALN

Senate Working Group Releases Bipartisan Measure to Reform 340B Program

Senate Working Group Releases Bipartisan Measure to Reform 340B Program  American Health Law Association

AHLAAug 6, 2026
90ALN

Building on States’ Medical Debt Protections: Closing Gaps in Standards, Access, and Enforcement

Building on States’ Medical Debt Protections: Closing Gaps in Standards, Access, and Enforcement  Commonwealth Fund

Commonwealth FundAug 6, 2026
90ALN

Highly Novel Drugs Outperformed Less Novel Drugs In Gross And Net Revenues In The US, Driven Primarily By Utilization, 2013–19

Highly Novel Drugs Outperformed Less Novel Drugs In Gross And Net Revenues In The US, Driven Primarily By Utilization, 2013–19  Health Affairs

Health AffairsAug 6, 2026